Ralph Duda
Endocrinology, Diabetes & Metabolism · Springfield, MONPI 1356436406
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $595,979 of the $644,268 with a category attached, or 92.5%. Lilly USA, LLC accounts for 79.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $166,521 and has fallen 53.6% since, to $77,300 in 2025. Among endocrinology, diabetes & metabolism clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 952 payments — averaging $676.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$511K
- Novo Nordisk$78K
- Amgen$50K
- Eli Lilly$3K
- Boehringer Ingelheim$2K
- Johnson & Johnson$70
- plus $236 from 7 others
Across 251 payments — averaging $9741.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2M
- Boehringer Ingelheim$147K
- AbbVie$98K
- Regeneron$79K
- Pfizer$75K
- AstraZeneca$39K
- plus $4K from 2 others
What the payments were for
- Consulting fees$4,0001%
- Speaking & faculty fees$595,97993%
- Travel & lodging$36,1756%
- Food & beverage$8,0191%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 735 | $511,298 |
| Novo Nordisk | 96 | $77,975 |
| Amgen | 70 | $50,393 |
| Eli Lilly | 22 | $2,590 |
| Boehringer Ingelheim | 10 | $1,705 |
| Johnson & Johnson | 5 | $70 |
| AbbVie | 4 | $56 |
| Mallinckrodt Hospital Products Inc. | 3 | $54 |
| UCB, Inc. | 3 | $50 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Radius Health, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$644,268 in reported general payments places this provider in the 95th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.
See all endocrinology, diabetes & metabolism providers in Missouri →
Other endocrinology, diabetes & metabolism in Springfield
- Jonben SvobodaSpringfield$142K
- James BonucchiSpringfield$128K
- Ana Rivas MejiaSpringfield$5K
- Karen Chang-ChenChesterfield$640K
- Alan RaubaJefferson City$594K
- Jerome ThurmanSaint Charles$312K
- Janet McGillSaint Louis$212K
- Megan WoodSt. Louis$207K
- Ralph OiknineChesterfield$144K
- Christopher CaseJefferson City$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.